What's New in Research Funding

Page last updated May 11, 2017.

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates:
 

May 11, 2017

  • 2017 Workshop: Strategies for Grant Writing and Innovation. Join us to learn more about: Services available through our office, Innovation at the University of Toronto, and Grant Writing and Development. 
    Hosted by the Office of the Vice Dean, Research and Innovation, Faculty of Medicine, UofT.
    Open to faculty, staff and post-doctoral fellows.
    Details here
    Location: Medical Sciences Building, MacLeod Auditorium, Room 2158
    Date: Thursday, June 15, 2017
    RSVP required. Register here.
     
  • CIHR/NSERC Collaborative Health Research Projects (CHRP): INFORMATION SESSION. The CIHR/NSERC CHRP program supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. CHRP projects require the translation of the research results to knowledge/technology users (KTUs) and related stakeholders outside the academic or training environment. ). Research Services Office, UofT, will provide an overview of the CHRP program and the application process including any internal U of T requirements.  Professor Craig Simmons, Distinguished Professor of Mechanobiology, and a multiple CHRP grantholder, will provide insight on the program from the researcher’s perspective as well as helpful tips learned from serving on the CHRP peer review committee.
    Location: Galbraith Buidling, Room 303, 35 St. George Street
    Date: Tuesday, May 16, 2017 from 2pm-3pm 
    RSVP to mark.bold@utoronto.ca by Friday, May 12.
     
  • NSERC Community Engagement Webinars. NSERC engagement visits have been a successful tool for the Agency and the community to share information and build linkages. Over the last four years, NSERC officials have made 48 visits to 39 universities. Moving forward, NSERC plans to continue connecting with the community in a more informal way.  NSERC is providing the Engagement visits in Webinar format as per the information below.
    (ENGLISH) Date: Wednesday, June 14, 2017, from 1pm - 3pm (ET)
    Conference number 1 877-413-4790
    Conference ID 7462843 7462843
    Link: http://nsercofcanada.adobeconnect.com/engagement-webinar/
     
  • Mitacs Elevate: Postdoctoral Fellowships, all disciplines. Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Mitacs Elevate is now accepting applications for two-year postdoctoral funding, which provides a $55,000 annual award (plus $7,500 per year non-cash value in training). Complete application information here. UofT Internal Deadline: May 31, 2017; Sponsor Deadline: June 7, 2017.
     
  • The Ted Rogers Centre for Heart Research - Education Fund (PhD/Fellowship): DEADLINE EXTENDED to May 12, 2017 at 5pm. Applicants must be enrolled as full-time students (as of Sept 1, 2017 or before) in a doctoral degree or postdoctoral research fellowship program, with involvement in cardiovascular research focusing on some aspect of heart failure. The proposed project must involve collaboration with at least 2 of 3 of the Centre’s partner organizations: Hospital for Sick Children (SickKids), University Health Network (UHN), and University of Toronto (UofT). Additionally, an applicant's supervisor must be affiliated with one or more of the partner organizations including other UofT affiliated academic health science centres, hospitals or research centres. 
     
  • Ministry of Research Innovation and Science (MRIS) Early Researcher Aware (ERA) - Round 13. The ERA program helps promising, recently-appointed Ontario researchers build their research teams of undergraduates, graduate students, post-doctoral fellows, research assistants, associates, and technicians. The ERA program will provide funding up to $100,000 for each award (plus $40,000 for indirect costs), and must be matched by an additional $50,000 (cash not in-kind) from the division/department and/or a partner organization. The funds are to be used over a period of five years to fund eligible expenses (e.g. salaries and benefits, essential and reasonable travel and expenses related to conferences for trainees, workshops, seminars, and/or offsite research activities) for building a research team. Eligible applicants are those who have started their academic career on or after July 1, 2012, and have completed their first Doctor of Philosophy, Doctor of Veterinary Medicine degree, Medical Doctor or terminal degree on or after July 1, 2007. The program will take into consideration eligible disruptions (such as required training and parental leave). UofT Deadline for NOIs: June 30, 2017. Please visit here for further details and how to apply.

May 3, 2017

  • NOTE -THIS COMPETITION* HAS BEEN DELAYED. Further information will be posted when available.
    *CIHR Project Grant Program: Spring 2017 Competition. Information for UofT, Faculty of Medicine, campus-based applicants (REMINDER)
    If you: a) will be submitting a proposal to this competition, b) will be administering your grant through a unit within the Faculty of Medicine, and c) wish to receive an editorial review of your proposal from our office, we ask that you submit your draft proposal to Grants and Awards Editor Daniel Harney –dan.harney@utoronto.ca – by Tuesday May 23rd. We acknowledge that this is ahead of the registration deadline (May 30th), but with CIHR only giving two weeks between the registration and application deadlines, this internal deadline is essential to allow time for a proper review. Please note that CIHR's anticipated notice of decision for the Fall 2016 competition is May 15, 2017. CIHR registration deadline: May 30, 2017  CIHR submission deadline: June 13, 2017 
     
  • University of Toronto: Connaught Global Challenge Award 2017-18 (REMINDER). The Global Challenge Award program will support new collaborations with UofT researchers and students from multiple disciplines, along with innovators and thought leaders from other sectors, with the goal of heightening the University of Toronto's contribution to important issues facing society through the advancement of knowledge, and the transfer and application of solutions. Awards will support symposia, workshops, visiting scholars, and other mechanisms for bringing diverse sets of expertise to bear on important global challenges. Open to all UofT full-time professorial staff (tenured or tenured stream), the funding scheme will have an annual funding envelop of $750,000, with grants up to $250,000 each. Application Deadline: June 1, 2017.
     
  • CIHR/NSERC Collaborative Health Research Program (CHRP). The CHRP Initiative funding supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. The CHRP Initiative funding requires the translation of the research results to knowledge/technology users (KTUs) and related stakeholders outside the academic or training environment. As such, the proposed research projects must have a strong focus on knowledge translation (KT) and lead to health and economic benefits for Canadians, more effective health services and products, and/or a strengthened health care system. KTU organizations should be meaningfully engaged throughout the research process, as appropriate, to inform research planning and design. UofT Internal Deadline: May 30, 2017; Deadline for LOIs due at CIHR: June 6, 2017. Full applications will be by invitation only.
     
  • Genomic Applications Partnership Program (GAPP) - Round 9. The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that promote the commercialization and translation of genomics-derived technologies which address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and tools. The program provides a unique opportunity for Receptor organizations to collaborate with an ’omics researcher, and to leverage their R&D investments with public funding. Visit here for details on how to apply and further information. Deadline for EOIs to Ontario Genomics and UofT: May 15, 2017 at 9am ET.
     
  • Mitacs Globalink Research Internships 2018. The Mitacs Globalink Research Internship (GRI) program is now accepting Faculty submissions for Summer 2018. GRI pairs Faculty in Canada with international undergrads for 12-week research projects from May to September. All disciplines are eligible. Top-ranked senior undergrads travel from Australia, Brazil, China, France, Germany, India, Mexico, Tunisia, and Saudi Arabia. Faculty can submit multiple projects and re-submit projects from previous years. UofT Internal Deadline: June 7, 2017; Sponsor Deadline: June 14, 2017. 
     
  • Westin Brain Institute - Canada: Rapid Response 2017. Seed funding to support novel, high-risk, high-reward translational research that accelerates the development of therapeutics for neurodegenerative diseases of aging. Up to $200,000 per project, for up to 18 months. Deadline for PD-related disease applications: May 9, 2017; Deadline for AD-related disease applications: July 5, 2017.
    INFORMATION WEBINAR
    (AD-related diseases): June 12, 2017 at 1pm ET. Register here.
     
  • The Myositis Association: Grants & Fellowships 2017.  Funding is available for research into any type of immune-mediated myositis. Fellowship funding is available for $50,000 per year for 2 years, and grant funding is available for a maximum of $75,000 per year for 2 years. Research grants support new or innovative myositis research projects. Research fellowships support a a young physician, or PhD scientist, who is beginning a career in myositis research in the laboratory of an established myositis investigator. Deadline for LOIs: May 15, 2017. Full applications due: June 16, 2017.
     
  • National  Centre for Responsible Gaming (NCRG): Gambling Disorders Research Funding. The NCRG is committed to a multi-disciplinary approach and, therefore, welcomes applications from investigators in psychology, psychiatry, epidemiology, public health, sociology, economics, neuroeconomics, neuroscience and other relevant disciplines. Funding is available for travel grants, seed funding and large grants. Deadline for LOIs (large grants): June 1, 2017; Deadline for applications (seed grants): August 1, 2017.
     
  • Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF): Familial RUNX1 Patient Samples Grant. The purpose of the grant is to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with FPD/AML. Projects should focus on leukemia caused by familial RUNX1 mutations rather than sporadic AML with somatic RUNX1 mutations.  Funding and grant duration depend on the research direction of interest but range between $250,000 and $500,000 USD over two years. Deadline for LOIs: July 1, 2017; Full Application Deadline: September 15, 2017.
     
  • The Hope Foundation: SWOG Early Exploration and Development (SEED) Fund. SWOG's mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors, primarily through design and conduct of clinical trials. Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). Individual projects may be funded for up to $50,000 USD (direct costs) and may be spent over a 1- or 2-year award period. Deadline for Applications: July 1, 2017.
     
  • Histiocytosis Association: Research Grants. Proposals for scientific research (both basic and clinical) are accepted for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. Proposals are evaluated on the basis of science, feasibility, and relevance. All proposals are expected to address one or more of the histiocytic disorders. Upper amount $50,000 USD. Deadline for Applications: July 1, 2017.

April 19, 2017

  • CIHR Announcement: Dr. Anne Martin-Matthews to serve as Acting Vice-President, Research, Knowledge Translation, and Ethics of CIHR. 
     
  • Message from Roderick McInnes, Acting President of CIHR. Changes to the upcoming Spring 2017 Project Grants competition and news about the Fall 2016 Project Grants competition.
     
  • Investing in Canada’s Future: Strengthening the Foundations of Canadian Research. Last June, Minister of Science Kirsty Duncan appointed an independent panel to review the Government of Canada’s funding mechanisms for fundamental science. Chaired by Dr. David Naylor, the esteemed panel criss-crossed the country to collect input from researchers, scientists, students and the Canadian public. The report is now available.
     
  • The CIHR Foundation Grant Program – Why and when you should apply: IHDCYH Webinar Series. Are you interested in applying for the Foundation Grant Program, but aren’t sure if it is the right decision for you? This webinar will help you identify whether this opportunity is right for you by reviewing key elements of the application process, including eligibility, how existing funding is dealt with, and how a foundation grant affects your current funding and ability to apply for other funding. The webinar will also include a Q&A session where we will discuss any issues and barriers to submission that you may be experiencing.
    • WEBINAR: May 2 at 1pm EST (register in advance) or
    • WEBINAR: May 15 at 2pm EST (register in advance)
  • Broad Institute: CARB-X Collaborative Hub for Early Antibiotic Discovery. The Collaborative Hub for Early Antibiotic Discovery (CHEAD) at the Broad Institute supports CARB-X by acting as an interdisciplinary center for early stage development of molecules identified by academic investigators engaged in antibiotic development and/or resistance research. CHEAD will partner with academic laboratories to evaluate and accelerate the development of promising small molecule therapeutics toward Investigational New Drug/Investigational Device Exemption (IND/IDE) application. Deadline for Applications: May 1, 2017.
     
  • amFAR: Mathilde Krim Fellowships in Basic Biomedical Research. The goal of amfAR's Mathilde Krim Fellowships in Basic Biomedical Research is to facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research within an academic or non-profit institution. Applicant fellows and mentors need not be U.S. citizens. Maximum funding is $150,000 for 2 years. Deadline for LOIs: May 9, 2017 at 3pm EDT.
     
  • Michael J. Fox Foundation for Parkinson's Research (MJFF): Computational Tools for PD Therapeutic Development. MJFF aims to support development of computational tools to facilitate production of novel biomedical measures relevant to defining PD. The following disciplines of computational methods are encouraged: Data processing functions to allow for enhanced analysis efficiency, and multi-modal statistical and computational methods. $150,000 USD for one year. Deadline for Preliminary Proposals: May 31, 2017.
     
  • Osteology Foundation: Osteology Researcher Grants. Funding research into all aspects of oral tissue regeneration is a core task of the Osteology Foundation. Studies are the engine of development. The Osteology Foundation provides funding for studies all over the world. The foundation provides Osteology Advanced Researcher Grants and Osteology Young Researcher Grants. Grants are limited to 100'000 or 30'000 Swiss francs with a maximum project duration of two years or one year, depending on the grant program. Deadline for Abstract Submissions: June 15, 2017.
     
  • Lung Cancer Research Foundation (LCRF): Research Grants. The Foundation encourages applications for projects investigating a wide variety of research topics, including:  Prevention and screening for early detection; Identification of new biomarkers and the development of targeted therapies; The development of next-generation chemotherapeutic agents; Supportive measures for people with lung cancer and their families; and Quality of care and outcomes research. Upper amount: $150,000 USD over 2 years. Deadline for Applications: July 1, 2017.
     
  • Alzheimer's Drug Discovery Foundation (ADDF):  Accelerating Drug Discovery for Frontotemporal Degeneration (Request for Proposals). Research investigating the pathologic mechanisms underlying frontotemporal degeneration (FTD) is advancing, creating new targets for drug discovery. The foundations seek to accelerate and support innovative drug discovery programs for FTD through this Request for Proposals (RFP). Upper amount: $150,000 USD for one-year. Deadline for LOIs: July 31, 2017.
     
  • Solving Kids' Cancer (SKC): Therapeutic Development Initiative (TDI) - Funding for High-Impact Pediatric Cancer Research. The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. Priority is given to proposals that introduce therapeutic agents and modalities which are first-in-children and have a strong potential to improve treatment outcomes. Funding award amounts generally range from $50,000 to $600,000 USD for up to 2 years. Deadline for Preliminary Proposals: Continuous.
     
  • Jain Foundation: Research Grants. The explicit goal of the Foundation is to expedite development of a treatment or cure for the dysferlinopathies (LGMD2B and Miyoshi Myopathy). A proposed project must have application to these diseases, or it will not be considered. The project must have direct relevance to dysferlin deficiencies - either to extend the understanding of the disease or a unique approach to a treatment for the disease. Deadline for Preliminary Proposals: Continuous.
     
  • ​NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) and (R21)
    • Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03) and (R21) and (R01)
    • Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)
    • Innovative Research in Cancer Nanotechnology (IRCN) (R01)
    • Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)
    • Extracellular Vesicles and Substance Use Disorders (R01) and (R21)
    • Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
    • Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
    • Integrative Computational Biology for Analysis of NHLBI TOPMed Data (R01)
    • From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative R01) and (R01)
    • Collaborative R01s for Clinical Studies of Mental Illness Not Involving Clinical Trials (Collaborative R01)

April 12, 2017

  • CFI - Cyberinfrastructure Initiative. The Canada Foundation for Innovation (CFI) has published the Call for Proposals for the second competition of Challenge 1 of the Cyberinfrastructure Initiative. In this competition, the CFI challenges institutions and researchers to come together to form consortia and propose research data infrastructure projects that create tailored, shared and integrated data resources (e.g. databases and data repositories) capable of enabling leading-edge research on significant scientific, social and economic questions. Projects submitted should bring together a community of researchers from across the country who share similar challenges linked to the availability of research data. Projects should address an existing or emerging challenge for this community through the development of new tools and applications or novel ways of organizing and using research data that would enhance the community's capacity to conduct leading-edge research. English WEBINAR to be held on April 26, 2017; French WEBINAR to held April 27, 2017. Details are forthcoming.
    UofT Internal deadline to submit NOIs: May 4, 2017; Sponsor deadline for NOIs: May 12, 2017. Visit the UofT webpage for complete timelines. 
     
  • CIHR Team Grant : Healthy Life Trajectories Initiative (HeLTI) - Canada. This funding opportunity is part of the HeLTI initiative, the goal of which is to shape national policy and decision-making around interventions during the earliest stages of life for the improvement of health and the prevention of later life non-communicable diseases, including cardiovascular diseases, diabetes, respiratory diseases and mental health. Thiscohort will align with the HeLTI Initiative’s Linked International Intervention Cohorts (HeLTI LIIC). Deadline for Applications: June 13, 2017. 
    • Information WEBINAR: April 21, 2017 at 12pm ET. Please register in advance.
       
  • CIHR: HIV/AIDS Comorbidities Prevention and Healthy Living Team Grants. The goal of the HIV/AIDS Comorbidities Prevention and Healthy Living Team Grants is to improve the health of people living with HIV/AIDS in Canada by supporting the development or enhancement of expert teams of investigators and their partners undertaking strategic collaborative, multi-disciplinary biomedical and clinical research relevant to the CIHR HIV/AIDS Strategic Plan. View the call in ResearchNet. Deadline for LOIs: June 20, 2017. 
  • The Westin Brain Institute: Postdoctoral Scholars 2017. This program provides salary support to top-tier Canadian postdoctoral scholars for international training at the University of Oxford, and affiliation with Merton College. The application deadline has been extended to July 26, 2017 at 2:00pm EDT, to provide more time for applicants to develop a strong collaboration and experimental approach with their potential supervisor at Oxford. The Award amount is £57,000/year (£44,000/year + benefits) for 2 years.
    • Information WEBINAR: May 16, 2017 from 1pm-2pm EDT. Register here.
  • Rettsyndrome.org - International Rett Syndrome Foundation: Research Grants Opportunities
    • Neuro-Habilitation Research Grant Program. Upper amount: $150,000 USD for 2 years. Deadline for LOIs: May 1, 2017
    • Translational Research Grant Program: HeART (Help Accelerate RTT Therapeutics). Upper amount: $150,000 USD for 2 years. Deadline for LOIs: May 8, 2017
    • Basic Research Grants. Upper amount: $150,000 USD for 2 years.​ Deadline for LOIs: May 22, 2017
    • Mentored Training Fellowships. Upper amount: $100,000 USD for 2 years.​​ Deadline for LOIs: June 5, 2017
  • ​Lam Foundation: Grants Opportunities. The LAM Foundation offers grant opportunities for researchers interested in studying lymphangioleiomyomatosis.  Deadline for LOIs: June 15, 2017. The LAM Foundation offers the following research awards and grants:  
    • Career Development Awards. Upper amount: $50,000 USD for up to 3 years.
    • Established Investigator Awards. Upper amount: $50,000 USD for up to 3 years.
    • Pilot Project Awards (available for the initiation of innovative research projects). Upper amount: $25,000 USD
    • Other awards (The LAM Foundation also considers proposals for clinical trials, bridge funding and other special projects.) 
       
  • Saving tiny Hearts Society (StHS): Research Grants. The Society awards research grants to early stage science with unique hypotheses fostering the next generation of congenital heart defect research creating a strong foundation of preliminary evidence to make scientific advancements. Priority will be given to well-designed hypothesis driven research that will impact the lives of children and adults living with congenital heart disease.  Upper amount: $75,000 USD for one year. Deadline for Proposals: July 15, 2017.
     

April 4, 2017

  • CIHR Announcement - Roderick McInnes: Acting President of CIHR. On March 31, 2017, the Honourable Jane Philpott, Minister of Health, announced that Dr. Roderick McInnes has assumed the responsibilities of Acting President of the Canadian Institutes of Health Research (CIHR).  Dr. McInnes is an internationally recognized researcher who brings extensive leadership experience to CIHR, having served as the inaugural Scientific Director of the Institute of Genetics, from 2000-2010. ​Dr. McInnes replaces Dr. Alain Beaudet, who was appointed as CIHR President in 2008.  In this acting assignment, Dr. McInnes will lead the organization until a permanent President is appointed by the government.
     
  • CIHR/SSHRC: Healthy and Productive Work - Partnership Grants. This initiative supports the development, implementation, evaluation and scaling up of evidence-based interventions (e.g. accommodations, tools and policies) taking into consideration sex, gender, age, and physical and mental health, to ultimately foster healthy, meaningful and productive work for all workers. View the full call in ResearchNet. Deadline for Applications: November 1, 2017.
     
  • Neuroscientist Catalyst Program. Neuroscience Catalyst is a public-private partnership between the University of Toronto, Janssen Inc. and the Johnson & Johnson Innovation center in California to fund collaborative pre-competitive, early-stage proof of concept research towards identifying and validating new therapeutic targets that can progress to the clinical treatment for mood disorders and Alzheimer’s disease. Neuroscience Catalyst was designed with the aim of leveraging the collective skills and resources of academia and industry to accelerate the pace of developing and bringing new neuroscience drugs to market and providing treatments for major brain disorders. The program is currently accepting applications on a rolling basis until July 14, 2017.
     
  • National Research Council of Canada (NRC): Postdoctoral Fellow Program. The NRC is excited to announce a new initiative to bring up to ten postdoctoral fellows (PDFs) to work alongside our internationally recognized research leaders. The program will offer PDFs access to unique world-class facilities and the opportunity to work alongside multi-disciplinary teams of expert researchers and technicians on projects of critical importance to Canada. PDFs will carry out research on innovative research projects, with opportunities for career development (publications and/or industry interaction). Deadline for Applications: April 23, 2017. 
     
  • Advancing Science Through Pfizer: Investigator Research Exchange (ASPIRE) Gene Therapy for Hemophilia Research Awards Program. The mission of the program is to support research through a competitive grants program that advances medical knowledge in the area of Gene Therapy for Hemophilia. The 2017 program will focus on Hemophilia B. Upper amount $250,000 USD for 1-2 years. Deadline for Applications: May 22, 2017.
     
  • Huntington's Disease Society of America (HDSA): HD Human Biology Project. HDSA is interested in sponsoring innovative lines of inquiry of human HD patient data that will shed light on the most proximal biological events caused by the mutant huntingtin gene. All research proposals must incorporate a patient-centric focus to understanding HD. Upper amount: $150,000 USD for up to two years. Deadline for Letters of Intent: May 22, 2017.
     
  • Lupus Research Institute (LRI): Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity. This a global program that will provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of lupus and so provide new directions toward a cure or prevention.  The  LRI welcomes novel, hypothesis- or discovery-driven proposals in human and/or animal model based lupus research. The research proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a potential cure, prevention, or highly effective therapy. Upper amount $1,000,000 USD for up to four years. Deadline for Applications: May 24, 2017.
     
  • Michael J. Fox Foundation for Parkinson's Research (MJFF): Inflammation Biomarkers for Parkinson's Disease (NEW). MJFF seeks to support research that will develop new or improve upon existing biomarker tools for neuroinflammation/peripheral inflammation in Parkinson's disease (PD). Visit their website to view their specific goals, modalities and subtopics. Upper amount $300,000 USD for 1-2 years. Deadline for Pre-proposals: May 31, 2017.
  • Care-for-Rare Science Award 2017. Endowed with 50,000€, the Care-for-Rare Science Award, sponsored by the Werner Reichenberger Foundation, aims to give scientists the chance to initiate a basic or clinical research project in the field of rare diseases. The Care-for-Rare Foundation supports interdisciplinary and international scientific projects with the goal to elucidate the causes of rare diseases and to develop new innovative therapies for affected children. The application is open for single persons or groups of scientists with at least one member being affiliated with a research institution located in Germany. Junior researchers are explicitly encouraged to apply. For further information please contact Dr. Henrike Klinker.  Deadline for Submissions: July 2, 2017.
     
  • JDRF Strategic Research Agreement: Single-, Multi-, and Clinical SRA Projects. JDRF’s Strategic Research Agreements provide research funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research. The Strategic Research Agreement is a partnership between Investigator(s) and JDRF Scientists to help address roadblocks and accelerate JDRF’s mission through support of cutting-edge scientific investigation. Deadline for Project Concept: August 1, 2017.
     

 

March 24, 2017
 

  • CIHR Project Grant Program: Spring 2017 Competition. Information for UofT, Faculty of Medicine, campus-based applicants. If you: a) will be submitting a proposal to this competition, b) will be administering your grant through a unit within the Faculty of Medicine, and c) wish to receive an editorial review of your proposal from our office, we ask that you submit your draft proposal to Grants and Awards Editor Daniel Harney – dan.harney@utoronto.caby Tuesday May 23rd. We acknowledge that this is ahead of the registration deadline (May 30th), but with CIHR only giving two weeks between the registration and application deadlines, this internal deadline is essential to allow time for a proper review. Please note that CIHR's anticipated notice of decision for the Fall 2016 competition is May 15, 2017.
    • CIHR registration deadline: May 30, 2017
    • CIHR submission deadline: June 13, 2017
       
  • ​CIHR Foundation Grant Program: 2017-2018 Competition. CIHR has officially announced the timelines for the next Foundation Grant Program (2017-2018). Compete details are now available in ResearchNet.
    • Registration deadline: August 8, 2017
    • Stage 1 application deadline: September 12, 2017
       
  • ​​​Diabetes Canada: 2017 Research Competition. Previously Diabetes Canada (formerly Canadian Diabetes Association) funded two separate annual research competitions: a Personnel Awards competition—which was comprised of three categories: Clinician Scientist Awards, Scholar Awards, and Post-Doctoral Fellowship Awards—and an Operating Grants competition. Under the redesigned research funding model, there will no longer be two research funding competitions. Instead, there will be one integrated research competition. The categories for this competition will be:
    • Post-Doctoral Fellowship: Salary support of $45,000 per year, plus a research allowance of $5000 per year, with a duration of funding of up to three years.
    • New Investigator Award: $125,000 per year for three years. Of this, the investigator may choose to allocate up to $50,000 per year for investigator's salary support.
    • Diabetes Investigator Award: $125,000 per year for five years (successful applicants who wish to use part of the award for salary will be asked to submit specific justification for review).
      • UofT internal (MRA) deadline (for institutional signatures): March 29, 2017
      • Sponsor deadline: April 3, 2017 at 8pm EDT through ResearchNet
  • Joule Innovation Grant Program: Physician-Led Innovations. As a Canadian Medical Association (CMA) company, JouleTM provides physicians with valuable products and services to help them perform at their best. Joule is uniquely positioned to advance physician-led innovation through grant funding, access to mentorship and knowledge-sharing opportunities. Through the Joule Innovation program, CMA members have access to $150,000 in flexible funding to invest in their venture where they need it most—to build a prototype, to commercialize, to scale their initiative—the possibilities are endless. Questions about Joule and the grant program should be directed to Kyle.brown@cma.ca, Senior Advisor, Business Intelligence & Strategy, tel: 613-266-0194.
    • UofT Internal Deadline: April 24, 2017
    • Deadline for Applications: May 1, 2017
       
  • NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Research Answers to NCI's Provocative Questions (R01) and (R21)
    • Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)
    • Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)
    • Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R01) and (R21)
    • Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21) and (R01)
    • Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01) and (R21)
    • From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01) and (U01)
    • NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)
    • Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) and (R03) and (R01)
    • Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms (R01)
    • NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)
    • NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)
    • Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01) and (R21) and (R03)
    • Hearing Health Care for Adults: Improving Access and Affordability (R01)
    • Nutrition and Alcohol-Related Health Outcomes (R01) and (R03) and (R21)
    • Inter-organelle Communication in Cancer (R01) and (R21)
    • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
    • Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)
    • Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01)
    • Mechanisms of Alcohol-associated Cancers (R21) and (R01)
       

March 21, 2017
 

  • George Weston & Loblaw Companies: Seeding Food Innovation 2017. This funding opportunity supports funding for rigorously scientific, trans-disciplinary research proposals that investigate food and health challenges that will impact primarily Canadians, but also deliver key learnings to solve issues of global concern. Funding of up to $150,000 per project is available for up to two years within the field of food innovation. Grants will only be awarded to institutions that are Canada Revenue Agency registered. Internal Deadline for LOIs: April 10, 2017; Sponsor Deadline: April 17, 2017.
     
  • The Ministry of Research, Innovation and Science (MRIS): Ontario Research Fund - Research Excellence Round 9. The ORF-RE program promotes research excellence of strategic value to Ontario by supporting new leading-edge, transformative, and internationally significant research. The ORF-RE focuses on research excellence and strong benefits to Ontario with this program that requires significant Private Sector partnership. The program will contribute towards eligible operating costs of an approved research project to a maximum of 1/3 of the total project costs, with 1/3 of the remainder coming from the applicant institution(s) and 1/3 from the private sector. Mandatory NoIs are to be submitted to Research Services (no MRA required) by April 25, 2017. View the funding opportunity for further details.
  • CIHR Team Grant: Human Immunology Initiative: Standardization and its application in autoimmune diseases research. The aim of the Standardization Core is to create common measurements, indicators and outcomes that can be used for comparative purposes across populations and studies, including identifying and addressing ethical issues. The successful applicant to the Standardization Core funding opportunity will constitute a best practices platform, and will be responsible for the development and validation of standard operating procedures (SOPs) in human immunology, applied to the field of autoimmune disease research, by aligning with work conducted at the international level.
  • CIFAR Azrieli Global Scholars Program. CIFAR announces a new opportunity for early career researchers.  This initiative invites outstanding early-career researchers to join one of nine research programs which address some of the most complex challenges facing the world today. The CIFAR Azrieli Global Scholars program provides funding and support to help you build your research network at this early stage in your career. The award includes a two-year appointment to a CIFAR program, $100,000 CDN in undesignated research support, and specialized leadership and communications training. Scholars are appointed to a research program, becoming part of a global network of leading researchers pursuing answers to some of the most difficult challenges facing the world today. Please visit their website for eligibility requirements, guidelines and eligible research themes. Questions should be directed to global.scholars@cifar.ca. Deadline for Submissions: May 23, 2017.
     
  • Canadian Liver Foundation: Operating Grants. Two operating grants may be awarded to researchers in Canada whose research projects are related to hepatobiliary research. One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer, and one operating grant (sponsored by F. Pauline Spence) may be awarded to a researcher in Ontario whose research project is related to hepatobiliary research. Deadline for Applications: March 31, 2017.
     
  • Bill and Melinda Gates Foundation: Grand Challenges Exploration (Round 19). GCE supports early-stage research projects - including many ideas that have never before been tested. The GCE initiative funds innovative ideas that could lead to new vaccines, diagnostics, drugs, and other technologies targeting diseases that claim millions of lives every year, as well as improvements and innovations in agriculture development and others of the Foundation priority areas. Deadline for Submissions: May 3, 2017. GCE round 19 challenges are:
  • Worldwide Cancer Research: Research Grants. The sponsor's goal is to fund scientific research that may, in future, help reduce the incidence of cancer or improve cancer survival. The sponsor awards project grants to support basic or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer. This definition is usually interpreted conservatively. Worldwide Cancer Research does not accept applications for clinical or psychosocial research and other types of applied cancer research. Upper amount: £250,000GBP for 1-3 years. Deadline for Submissions: April 21, 2017 at 17:00 British Summer Time.
     
  •  ALS Association and CReATe Consortium. Biomarker Development Validation: 2017 Request for Applications. The purpose of this RFA is to support the discovery and/or validation of biomarkers that are relevant to the development of therapies for patients with ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]). Proposals to develop either wet (e.g. biological-fluid based) or dry (e.g. neuroimaging, neurophysiological) biomarkers are encouraged. Investigators submitting an application in response to this RFA may also request to use the data and/or biological samples collected by the CReATe Consortium. Any individual with the requisite scientific training, irrespective of country of residence or origin, may submit an application in response to this RFA. Upper Amount: $60,000 USD. Deadline for Letters of Intent: April 7, 2017.
     
  • ALS Association: Translational Research Advancing Therapy for ALS (TREAT ALS) / The Lawrence and Isabel Barnett Drug Development Program - BRIDGE GRANTS. The ALS Association's TREAT ALSTM program funds research from early target identification to preclinical research and early pilot clinical trials. As part of the program, The Association is requesting letters of intent for its drug development contract program, milestone driven research to develop new treatments for ALS. The program compliments the Department of Defense ALS research program and the translational programs at the National Institutes of Health and specifically aims to support studies that will de-risk and incentive industry partners to further pursue interesting targets. Upper amount: $500,000 USD; Lower $50,000 USD. Deadline for Letters of Intent: May 23, 2017; Deadline for Full Applications: September 4, 2017.

 

March 8, 2017
 

  • Catalyst Grant: Population Health Intervention Research Related to the Legalization of Cannabis in Canada (PRE-ANNCOUNCEMENT). This funding opportunity is aimed at helping researchers plan and develop studies on the impact of cannabis legalization (the intervention under study) as an initial step contributing to a future funding program to answer key questions related to the health and social impact of this change in policy. The total amount available for this opportunity is currently $1 million over one year for up to 10 grants. Anticipated Launch Date: April 2017. 
     
  • CIHR Update from the Chairs of the College of Reviewers. In this update, Dr. Paul Kubes and Dr. Jane Rylett provide an overview of the College Chairs’ progress to date, as well as their plans for the immediate future.
     
  • HUB Session: Are you thinking about `value for money`of your research? Given the limited resources we are faced with in health care, the ability to apply economic thinking when making a choice or a decision can be beneficial. This talk will introduce economic evaluation, its potential role in research, when to consider to this technique, and a practical example of how economic evaluation has been used to demonstrate value for money. The goal of economic evaluation is to provide another piece of evidence to assist researchers, health providers, decision-makers, and policy-makers in their decision-making process. If you are thinking about “value for money” of your work/research, economic evaluation could be a technique to consider. Registration is required.
    Date: Wednesday, March 16, 12:30pm - 2pm
    Location: MS 2170, Medical Sciences Building, UofT, 1 King's College Circle
     
  • Joule Innovation Grant Program - Physician-Led Innovations. As a Canadian Medical Association (CMA) company, JouleTM provides physicians with valuable products and services to help them perform at their best. Joule is uniquely positioned to advance physician-led innovation through grant funding, access to mentorship and knowledge-sharing opportunities. Through the Joule Innovation program, CMA members have access to $150,000 in flexible funding to invest in their venture where they need it most—to build a prototype, to commercialize, to scale their initiative—the possibilities are endless. Questions about Joule and the grant program should be directed to Kyle.brown@cma.caDeadline for Applications: May 1, 2017.
     
  • Cystinosis Research Foundation. The CRF is prepared to fund proposals to improve the immediate care of children and adults with cystinosis and to develop a new understanding and treatment of cystinosis in an effort to help these patients in the future. The Foundation will support bench, translational and clinical research. Deadline for Proposals: April 10, 2017.
     
  • Sanfilippo Children's Foundation. The mission of the Sanfilippo Children's Foundation is to drive research, enable access to effective treatments and improve the quality of life for Australian children affected by the fatal childhood disease, Sanfilippo Syndrome.  Funding is available for Translation Research Grants and Incubator Grants. Upper Amount $1,500,000 AUD. Deadline for Expressions of Interest: April 3, 2017; Full Proposal Deadline: May 19, 2017.

February 28, 2017
 

  • CIHR: HIV/AIDS Prevention and Healthy Living Team Grants (PRE-ANNOUNCEMENT). This funding opportunity aims to address the CIHR HIV/AIDS strategic research priority area of biomedical and clinical research. The goal of the HIV/AIDS Prevention and Healthy Living Team Grants is to improve the health of people living with HIV/AIDS in Canada by supporting the development or enhancement of expert teams of investigators and their partners undertaking strategic collaborative, multi-disciplinary biomedical and clinical research relevant to the CIHR HIV/AIDS Strategic Plan. Anticipated Launch Date: April 2017.
     
  • 2017 Microbiome Summer School: Big Data Analytics for Omics Science - June 18-22, 2017, Québec City. The primary objective of this summer school is to meet the needs in bioinformatic training for the Canadian microbiome research community through introductory “state-of-the-art” bioinformatic courses. Machine learning approaches will be incorporated. This course is aimed at individuals intending to or working in microbiome research with a biomedical/health perspective who want to gain experience in bioinformatics. Applicants are expected to be embarking on bioinformatics related projects or need to use such approaches in their work. Deadline for submission of candidature: March 17, 2017.
     
  • UofT Completion Award Application. Under the jurisdiction of the Vice-President, Research and Innovation, the General Research Fund supports a number of research initiatives through an annual allocation. One of these initiatives is the University of Toronto Research Completion Award (RCA) program which provides funding to researchers whose SSHRC or NSERC grant has recently expired with an unspent balance that will be transferred to the GRF and who have been unable to complete the research project due to extenuating circumstances or require funds to advance their originally approved research project in order to position themselves for re-application to NSERC or SSHRC. Questions about the RCA program may be directed to jessica.keating@utoronto.ca or 416-978-1614. Deadline for applications through MRA: April 17, 2017.
     
  • Canadian Centre for Aging and Brain Health Innovation: Researcher Clinician Partnership Program (RCP2). This program is uniquely designed to greatly enhance the effectiveness of connecting point-of-care clinicians in the senior care sector with university-based researchers to collaboratively design, test and validate innovative products, services or health practices in aging and brain health in a real-world care setting.  They are now seeking applicants with innovations that are aimed at finding solutions to specific care priorities for older adults living with dementia and Alzheimer's, or are targeted at improving cognitive fitness in the aging population. Through RCP2, CC-ABHI will provide up to $600,000 in funding per project to support those project costs directly associated with the trial testing of an innovative solution at an advanced stage of development within an aging population group in North America.  UofT Internal Deadline: March 23, 2017; Sponsor Deadline: March 30, 2017.
     
  • AGE-WELL 2017: Strategic Investment Program (SIP) Accelerator Funding. AGE-WELL is dedicated to the creation of technologies and services that benefit older adults and caregivers, with the aim of helping older Canadians maintain their independence, health and quality of life through technologies and services that increase safety and security, support independent living, and enhance social participation. The aim of the SIP Accelerator Program is to support innovative post-discovery projects focused on the commercialization and/or knowledge mobilization of solutions (e.g. technologies, services or policies) aligned with AGE-WELL's mission and vision. Up to $40,000 over 12 months. UofT Internal Deadline: April 21, 2017; Sponsor Deadline: April 28, 2017.
     
  • HUB Session: Interpreting Common StatisticsThis Seminar will cover how to analyze data and interpret results using methods such as the t-test, chi-squared test, linear and logistic regression. We will also explore the concepts behind hypothesis testing and confidence intervals. Registration is required. Date: March 6, 2017, 9:30am - 11:00 am. Details here.
     
  • Lab Equipment for Sale. The following two items are for sale. For more information please contact laura.riley@utoronto.ca, 416-978-8310
    • Forma Scientific: 6 ft Laminar flow hood with stand - certified until 2017. $2,000 or reasonable offer
    • Molecular devices: QPix 2 XT colony picker robot. $15,000 or reasonable offer.
       
  • Weston Brain Institute.
    • Transformational Research 2017. Funding (maximum of $1,500,000 over up to 3 years) for high-potential translational research projects with excellent preliminary data. Deadline EXTENDED to March 31, 2017.
    • Canada: Rapid Response 2017. Seed funding to support novel, high-risk, high-reward translational research that accelerates the development of therapeutics for neurodegenerative diseases of aging. Up to $200,000 per project, for up to 18 months. Deadline for PD-related disease applications: May 9, 2017; Deadline for AD-related disease applications: July 5, 2017.
    • Postdoctoral Scholars 2017. Funding (£57,000 per year for 2 years) to support top-tier Canadian postdoctoral scholars by providing salary support for international training at the University of Oxford and affiliation with Merton College. WEBINAR: March 7, 2017, 1pm-2pm; Deadline for applications: April 11, 2017.
  • Kidney Foundation of Canada: Alport Syndrome Research Funding Program. The objective of this research funding program is to advance the knowledge of, develop effective treatment protocols for, and discover a cure for Alport Syndrome Foundation. Funding will be provided for basic science or clinical research on Alport Syndrome. Deadline for Applications: March 29, 2017.
  • Alliance for Cancer Gene Therapy (ACGT): 2017 Investigator's Award in Clinical Translation of Cell and Gene Therapies for Cancer. ACGT is accepting grant applications to produce and release-testing of the clinical trial agents under cGMP, conduct the necessary pre-clinical pharmacological and toxicological studies in appropriate animal models, and/or conducting the clinical translational trials in patients in support of an Investigative New Drug (IND) application to the FDA. While the unambiguous demonstration of PRECLINICAL TREATMENT EFFICACY DATA IN TUMOR-BEARING ANIMALS in cancer treatment by cell and gene therapy is a pre-requisite, entering into the clinical trial during the funding period is also a requirement. Deadline for LOIs (abstracts): March 21, 2017.
     
  • Orphan Disease Centre (ODC) at the University of Pennsylvania: 2017 Pilot Grant Program for CDKL5 Deficiency. CDKL5 Deficiency is a monogenic, orphan condition characterized by treatment-resistant epilepsy and severe cognitive and motor disability. The ODC will provide a one-year grant for $150,000.00 (total cost) to support research related to CDKL5 – number of awards may vary. View the call for details. Deadline for LOIs: March 9, 2017.
     
  • Advancing Science through ​Pfizer: Investigator Research Exchange (ASPIRE) Gene Therapy for Hemophilia Research Awards Program. The 2017 ASPIRE Gene Therapy in Hemophilia Research Awards Program is designed to support laboratory and clinical research in pathogenesis, complications, management, and clinical outcomes of gene therapy for hemophilia. $125,000 USD per year for 1-2 years. Deadline for Applications: March 31, 2017.
     
  • The Rising Tide Foundation: Clinical Cancer Research Grants. Rising Tide Foundation supports truly innovative, unique, patient-centered research that has the potential to positively impact the lives of cancer patients in near future. They fund early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact. They do not support basic research or phase III/IV trials. The amount of each award is based on availability of funds for up to 5 years. Deadline for Letters of Intent: April 20, 2017 or August 20, 2017.
     
  • Cystic Fibrosis Foundation: Research Grants. Research grants are intended to support basic science research. Studies may be carried out at the subcellular, cellular, animal or patient levels. To be considered, proposals must be hypothesis-driven and provide sufficient preliminary data to justify Cystic Fibrosis Foundation support. Upper amount $100,000 per year for up to two years. Deadline for Applications: April 19, 2017.
     
  • NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01) 
    • Advancing Our Understanding of the Brain Epitranscriptome (R21) and (R01)
    • Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01) and (R21)
    • Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01)
    • Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03)
    • NCMRR Early Career Research Award (R03)
    • Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01)
    • Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34)
    • Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)
    • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)
    • HIV pathogenesis and the oral microbiota (R01)
    • Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01) and (R21)
    • Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
    • Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)

 

February 13, 2017

  • Connaught Global Challenge Award 2017-18The Global Challenge Award program will support new collaborations with UofT researchers and students from multiple disciplines, along with innovators and thought leaders from other sectors, with the goal of heightening the University of Toronto's contribution to important issues facing society through the advancement of knowledge, and the transfer and application of solutions. Awards will support symposia, workshops, visiting scholars, and other mechanisms for bringing diverse sets of expertise to bear on important global challenges. Open to all UofT full-time professorial staff (tenured or tenured stream), the funding scheme will have an annual funding envelop of $750,000, with grants up to $250,000 each. Application Deadline: June 1, 2017.
     
  • 2017 NSERC Collaborative Research and Training Experience (CREATE):  INFORMATION SESSION. NSERC’s CREATE program awards grants of up to $1.65M over 6 years for the development of innovative training programs that enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce. Learn more about this program at our Information Session.  Dr. Luis Seco, a former CREATE Committee member will give insights on the program and the application process: 
    Monday February 27, 2017 3pm-5pm
    McMurrich Building, 12 Queen's Park Cres. West, Room 107
    Please RSVP by February 24th to joanna.baylon@utoronto.ca
     
  • Banting Research Foundation/McLaughlin Centre Discovery Award. The Banting Research Foundation and the University of Toronto McLaughlin Centre have announced a two-year funding partnership to support research by early career investigators focused on areas relevant to genomic medicine. Eligible applicants must be in the first three years of an academic appointment at the University of Toronto or its affiliated hospitals and their research institutes. 
    Institutional Support: the application must be accompanied by a letter of nomination from the applicant’s host department or division (note that a department/division head will be permitted to nominate only one potential applicant during each annual granting cycle). Applicants should contact their university or research institute departmental office concerning this nomination letter. Sponsor contact: Roman Rea (banting.foundation@utoronto.ca) 416-595-9046.
    Application Deadline: March 15, 2017.
     
  • CIHR Team Grant: Human Immunology Initiative: Standardization and its application in autoimmune diseases research. The aim of the Standardization Core is to create common measurements, indicators and outcomes that can be used for comparative purposes across populations and studies, including identifying and addressing ethical issues. The successful applicant to the Standardization Core funding opportunity will constitute a best practices platform, and will be responsible for the development and validation of standard operating procedures (SOPs) in human immunology, applied to the field of autoimmune disease research, by aligning with work conducted at the international level. A webinar will be announced at a later date. Deadline for Letters of Intent: June 6, 2017.
     
  • Canadian Liver Foundation: Operating Grant Program. In 2017, four operating grants may be awarded: 
    Two operating grants may be awarded to researchers in Canada whose research projects are related  to hepatobiliary research.
    One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer.
    One operating grant (sponsored by F. Pauline Spence) may be awarded to a researcher in Ontario whose research project is related to hepatobiliary research.
    Deadline for Applications: March 31, 2017.
     
  • Canadian Blood Services: 2017 MSM Research Grant Program. The objective of the MSM Research Program is to ensure the generation of adequate evidence-based research for alternative screening approaches for blood or plasma donors, which could evolve the current deferral policy for men who have sex with men (MSM) while maintaining the safety of the blood supply. Deadline for Registration: February 26, 2017: Application Deadline: April 30, 2017.
     
  • Alzheimer's Association: International Research Grant Program. The Alzheimer's Association funds a wide variety of investigations by scientists at every stage of their careers. Each grant is designed to meet the needs of the field and to introduce fresh ideas in Alzheimer's research. Deadline for Letters of Intent: March 1, 2017.
    • Research Grants (AARG)
    • Research Grants to Promote Diversity (AARG-D)
    • Research Fellowships (AARF)
    • Research Fellowships to Promote Diversity (AARF-D)
    • Clinician Scientist Fellowship (AACSF)
    • Clinician Scientist Fellowship to Promote Diversity (AACSF-D)
  • Cystic Fibrosis Foundation (CFF): Pilot and Feasibility Grants. The intent of these awards is to enable investigators to collect sufficient data to compete successfully for support from the NIH or other funding agencies. Special consideration will be given to those projects that propose innovative and creative approaches to the problems of cystic fibrosis. Applicants need not be U.S. citizens or hold a U.S. permanent visa to apply for this award. Deadline for Applications: April 19, 2017.
     
  • National Center for Responsible Gaming (NCRG): Large Grants for Research on Gambling Disorders. The Large Grants program provides support for discrete, specified, circumscribed research projects related to gambling disorders. Deadline for Letters of Intent: June 1, 2017. 

 

February 3, 2017

  • CIHR: JPIAMR Joint Call: Prevention and Intervention Strategies to Control AMR  Infections. The call targets research in the following topic: Comparison of prevention, control, and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches. Each transnational consortium is expected to include partners from at least 3 participating countries, but no more than 6. The total amount available for the Canadian component of successful projects is $3M, enough to fund approximately three (3) to five (5) grants. Read the call for complete details. Deadline for Pre-proposals: March 21, 2017; Deadline for Full Proposals: July 4, 2017.
     
  • LAUNCH: SickKids–CIHR-IHDCYH New Investigator Research Grants in Child and Youth Health. New Investigator Research Grants provide important early career development support to child health researchers. Grant recipients may obtain up to 3 years' support for research in biomedical, clinical, health systems and services, population and public health sectors. The maximum amount for a single grant is $100,000 per year for up to 3 years. Application Deadline: April 20, 2017.
     
  • CIHR: Health System Impact Fellowships. A NEW funding opportunity for PhD graduates (post-docs) who are interested in applying their research and analytic talents to critical challenges faced by health system and related organizations outside of the traditional scholarly setting, and who want to benefit from professional work experience, mentorship from health system and academic leaders, and professional development training in an expanded set of competencies (e.g., leadership, project management, change management) designed to accelerate professional growth. Application Deadline: May 9, 2017.
  • 2018 NSERC Collaborative Research and Training Experience (CREATE)The CREATE Program supports the training of teams of outstanding students and postdoctoral fellows from Canada and abroad through the development of innovative training programs that encourage collaborative and integrative approaches, address significant scientific challenges associated to Canada's research priorities, and facilitate the transition of new researchers from trainees to productive employees in the Canadian workforce. This year, the CREATE Program offers three additional opportunities within its current budget envelope. These include an Industrial Stream and an International Collaboration with Germany or Brazil. UofT Internal Deadline for LOIs: April 3, 2017 (FIRM): Sponsor Deadline: May 1, 2017.
    NSERC will be hosting two information sessions via webinar:
  • McLauglin Centre - Genomic Medicine Canada 2017: A symposium to discuss precision medicine initiatives.
    Date:
    March 1, 2017, 8:30am - 5:00pm
    Sponsors: The University of Toronto McLaughlin Centre, Canada’s Genomic Enterprise (CGEn), and partners
    Location: Peter Gilgan Centre for Research and Learning Auditorium, The Hospital for Sick Children, 686 Bay Street, Toronto
    Information and registration here
     
  • uFluidix: Prototyping Grant (In-kind application competition): This no-strings-attached Prototyping Grant was developed for start-ups and individual inventors who have a novel product with a microfluidic component. The winners of the Prototyping Grant will obtain free design and fabrication services from uFluidix for the development of their microfluidic prototypes. The dollar value of offered services is USD 50,000 for one year. Questions should be directed to Kateryna Protskyk, Program Manager, The Microfuidic Circle.
     
  • Cancer Research Society: Scholarships for the Next Generation of Scientists - 2017 Competition. This initiative is aimed at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.
    Part 1: Postdoctoral Salary Award -  1 year -  $40,000
    Part 2: Operating Grant  -   2 years - $120,000 ($60,000/year)
    Deadline for Applications: April 28, 2017
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Zika Virus (ZIKV) Complications (R21)
    • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)
    • Perception and Cognition Research to Inform Cancer Image Interpretation (R21) and (R01)
    • Juvenile Protective Factors and Their Effects on Aging (R01) and (R03)
    • Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
    • Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)
    • Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21) and (R03) and (R01)
    • Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01) and (R21)
    • International Research in Infectious Diseases, including AIDS (R01)
  • Congressionally Directed Medical Research Programs (CDMRP) - Funding Opportunities. US Department of Defense (DOD) Office of the CDMRP has released pre-funding announcements for the following research programs: Multiple Sclerosis, Ovarian Cancer, Tuberous Sclerosis Complex, and Peer Reviewed Orthopaedic Research Programs. Descriptions of each of the funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement at http://cdmrp.army.mil
     
  • Alzheimer's Drug Discovery Foundation (ADDF): Request for Proposal - Biomarkers Development. This RFP seeks to support the development and validation of novel and existing biomarkers that will enhance the design and performance of clinical trials for Alzheimer's disease, related dementias, and cognitive aging. The average award will be in the range of $150,000-$300,000 per year. The average award duration is 1-2 years. Deadline for LOIs: February 17, 2017 or May 19, 2017.
     
  • amfAR: Innovation Grants - Exploring the potential for HIV eradication. The purpose of this RFP is to fund biomedical research necessary to inform and design interventions to 1) cure HIV, defined by the eradication of all pathogenic virus from the body, or 2) bring about a state of remission whereby the virus is controlled in the absence of ART and the person is no longer infectious. Upper amount is $200,000 USD over 2 years. Registration Deadline: February 16, 2017; Deadline for LOIs: February 22, 2017.
     
  • Prostate Cancer Foundation: 2017 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. Team science awards are composed of at least three investigators from non-profit academic research centers, including one young investigator. They are intended to support large-scale research projects concerning metastatic, lethal prostate cancer over a duration of two years and provide up to $1 million USD per team. Deadline for Applications: April 24, 2017.​

January 19, 2017

  • Banting Research Foundation/Rick Hansen Institute Discovery Award. The Banting Research Foundation and the Rick Hansen Institute have announced a funding partnership to support research by early career investigators focused on areas relevant to spinal cord injury (SCI). This Discovery Award will support research which could potentially enable medical breakthroughs and transformative health care advances to reduce the human and economic costs associated with SCI. Eligible candidates must be focused on research in one or more of the following areas relevant to SCI: paralysis, pressure ulcers, urinary tract infections, neuropathic pain, predictive preclinical models of evaluation, and spinal cord injury in Indigenous Peoples in Canada. Eligibility is not limited to those specializing in the field of SCI, but the research must be applicable to SCI. Upper Amount $25,000. Deadline for Applications: March 15, 2017.
     
  • Big Data in Health and Biomedical Research - Call for Joint Projects. Tel Aviv University (TAU) - University of Toronto Joint Research Projects support and promote projects carried out collaboratively by TAU and UofT through identified fields of interest. The field of interest for this Call is Big Data in Health and Biomedical Research. Principal Investigators are invited to jointly submit proposals for the development of collaborative research projects and the exchange of researchers between TAU and UofT. Deadline for Proposals: March 9, 2017.
     
  • Ontario Brain Institute - 2017 ONtrepreneurs Program. This program provides an opportunity for Ontario's next generation of entrepreneurs to access much-needed funding and support for the launch or growth of their neurotechnology startup company. The 12-month program awards $50,000 cash and includes mentorship, training, and a number of value-add opportunities. UofT Internal Deadline: March 10, 2017; Sponsor Deadline: March 17, 2017.
     
  • CIHR Personalized Health Catalyst Grants (and INFORMATION WEBINAR). The purpose of this funding opportunity is to support researchers to maximize and leverage previous collaborative investments in personalized medicine, e-health and data platforms by driving evidence-based implementation of personalized health solutions that can contribute to more cost-effective and sustainable health care. Deadline for Registration: February 14, 2017; Application Deadline: June 13, 2017.
    INFORMATION WEBINAR: Friday, January 27, 2017; 1pm - 2pm ET.
    Webinar access (meeting number 550360853, password CIHR), Toll-free #: 1-877-413-4781; Conference code: 769 622 9
     
  • CIHR Team Grant: More Years / Better Lives (2017). The Joint Programming Initiative (JPI) “More Years, Better Lives – The Potential and Challenges of Demographic Change” seeks to enhance coordination and collaboration between European and national research programmes related to demographic change. This funding opportunity “Aging and place in a digitising world” is concerned with the ways in which the health and wellbeing of older people, at all stages of later life, is supported and promoted through the design of the social and physical environment, access to opportunities to learn, and the use of technologies of all kinds. Innovative, transnational and interdisciplinary collaborative projects that investigate the potential of technology, place and learning in relation with the older adult. Detailed information here.  Application Deadline: April 3, 2017.
     
  • HUB Session: Grants and Grantsmanship. This session provides information and tips on how to refine the clinical question and build a study rationale, identify core study team members as well as collaborators and infrastructure, communicate research impact and knowledge translation, and develop a study budget, identify considerations for study design, and frame a research question using the PICOT model. Registration is required. Date: January 23, 2017: 10-11:30am. Details here.
     
  • Prostate Cancer Foundation: 2017 PCF Young Investigator Awards. PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients. View and dowload the RFA. Deadline for Applications: March 13, 2017, 3pm EDT.
     
  • NIH Update Font Guidelines for applications to due dates on or after January 25, 2017.
     
  • NIH: Various OpportunitiesUnless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Fertility Status as a Marker for Overall Health (R01) and (R21)
    • Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01)
    • HIV-1 infection of the Central Nervous System (R01)
    • NINDS Efficacy Clinical Trials (U01)
    • Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21) and (R01)
    • Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21) and (R01)
    • Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21) and (R01) 
    • Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
    • NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
    • Chronic Condition Self-Management in Children and Adolescents (R01) and (R21)
    • Reducing Health Disparities Among Minority and Underserved Children (R21) and (R01)
    • Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
    • NINDS Exploratory Clinical Trials (R01)
       
  • Human Frontier Science Program (HFSP) Research Grants: Young Investigators' Grants and Program Grants. Research grants are provided for teams of scientists from different countries who wish to combine their expertise in innovative approaches to questions that could not be answered by individual laboratories. Emphasis… more » is placed on novel collaborations that bring together scientists preferably from different disciplines (e.g. from chemistry, physics, computer science, engineering) to focus on problems in the life sciences. Registration Deadline: March 20, 2017; Deadline for LOIs: March 30, 2017.
     
  • Alzheimer's Research UK (ARUK): Global Clinical Trials Fund. The Global Clinical Trials Fund supports clinical trials that have potential to be of benefit to dementia patients. Lead applicants and trial sites can be from the UK or international. Deadline for EOIs: May 10, 2017. The remit of this scheme covers): 
    • ​Studies that aim to demonstrate target engagement, Phase I or Phase II clinical trials undertaken to ascertain the potential safety and efficacy of (novel or re-purposed) drug-based interventions in human subjects.  
    • Clinical trials of non-drug based, complex interventions.
    • Opportunities for research 'add ons' to ongoing clinical trials (e.g. biomarker add-ons)
       
  • ALS Association: Milton Safenowitz Post Doctoral Fellowship for ALS Research Awards. The ALS Association Research Investigator-Initiated Research Grant Program supports innovative research of high scientific merit and relevance to amyotrophic lateral sclerosis (ALS). Preliminary data is required and can be data generated in the PI's laboratory not necessarily generated by the applicant. All nationalities are welcome to apply and awards are made to non U.S.A. based investigators. The maximum amount awarded is $50,000 per year for 2 years. Deadline for Abstract Submissions: January 31, 2017; Application Deadline: March 24, 2017.
     
  • LGS (Lennox-Gastaut Syndrome) Foundation Research Grant Program. The LGS Foundation's seed grant program awards research grants to young investigators, physician residents, and clinicians who are interested in studying Lennox-Gastaut Syndrome (LGS), a rare and often debilitating form of childhood-onset epilepsy. Seed Grants $30,000 USD for a one-year grant. Post-Doctoral Fellowships are two-year grants up to $50,0000 USD ($25,000/year). International applicants are welcome to apply. Deadline for LOIs: March 1, 2017; Application Deadline: April 1, 2017.

 

 

Back to Top